Drug Dealing and Grand Theft – Now Legal 

$62.7

Million

55%

Drop in stock price

For the 7 months during 2016 that he was CEO of Valeant Pharmaceuticals, Joseph Papa was paid $62.7 million.

Papa started in May of last year. During his tenure in 2016, Valeant's stock price fell 55%, the company lost $2.4 billion and revenue declined 7.4%.

— Source: 

https://www.morningstar.com/news/dow-jones/us-markets/TDJNDN_201703241304/valeant-paid-ceo-627-million-total-wsj.html

Leave a Reply

Your email address will not be published. Required fields are marked *

Best comments get a free hardcover copy of Living Sanely in an Insane World. We'll email you for your address if you're selected.